161 related articles for article (PubMed ID: 8850464)
61. Photodynamic therapy with intratumoral administration of Lipid-Based mTHPC in a model of breast cancer recurrence.
D'Hallewin MA; Kochetkov D; Viry-Babel Y; Leroux A; Werkmeister E; Dumas D; Gräfe S; Zorin V; Guillemin F; Bezdetnaya L
Lasers Surg Med; 2008 Oct; 40(8):543-9. PubMed ID: 18798287
[TBL] [Abstract][Full Text] [Related]
62. Short- and long-term normal tissue damage with photodynamic therapy in pig trachea: a fluence-response pilot study comparing Photofrin and mTHPC.
Murrer LH; Hebeda KM; Marijnissen JP; Star WM
Br J Cancer; 1999 May; 80(5-6):744-55. PubMed ID: 10360652
[TBL] [Abstract][Full Text] [Related]
63. Photodynamic dose does not correlate with long-term tumor response to mTHPC-PDT performed at several drug-light intervals.
Wang KK; Mitra S; Foster TH
Med Phys; 2008 Aug; 35(8):3518-26. PubMed ID: 18777912
[TBL] [Abstract][Full Text] [Related]
64. Doppler optical coherence tomography to monitor the effect of photodynamic therapy on tissue morphology and perfusion.
Aalders MC; Triesscheijn M; Ruevekamp M; de Bruin M; Baas P; Faber DJ; Stewart FA
J Biomed Opt; 2006; 11(4):044011. PubMed ID: 16965168
[TBL] [Abstract][Full Text] [Related]
65. Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy.
Kübler AC; de Carpentier J; Hopper C; Leonard AG; Putnam G
Int J Oral Maxillofac Surg; 2001 Dec; 30(6):504-9. PubMed ID: 11829232
[TBL] [Abstract][Full Text] [Related]
66. Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy.
Vrouenraets MB; Visser GW; Stewart FA; Stigter M; Oppelaar H; Postmus PE; Snow GB; van Dongen GA
Cancer Res; 1999 Apr; 59(7):1505-13. PubMed ID: 10197621
[TBL] [Abstract][Full Text] [Related]
67. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.
Moore CM; Nathan TR; Lees WR; Mosse CA; Freeman A; Emberton M; Bown SG
Lasers Surg Med; 2006 Jun; 38(5):356-63. PubMed ID: 16392142
[TBL] [Abstract][Full Text] [Related]
68. Efficacy of temoporfin-loaded invasomes in the photodynamic therapy in human epidermoid and colorectal tumour cell lines.
Dragicevic-Curic N; Gräfe S; Gitter B; Fahr A
J Photochem Photobiol B; 2010 Dec; 101(3):238-50. PubMed ID: 20797872
[TBL] [Abstract][Full Text] [Related]
69. Treatment of malignant melanoma by high-peak-power 1064 nm irradiation followed by photodynamic therapy.
Busetti A; Soncin M; Jori G; Kenney ME; Rodgers MA
Photochem Photobiol; 1998 Sep; 68(3):377-81. PubMed ID: 9747592
[TBL] [Abstract][Full Text] [Related]
70. m-THPC-mediated photodynamic therapy (PDT) does not induce resistance to chemotherapy, radiotherapy or PDT on human breast cancer cells in vitro.
Hornung R; Walt H; Crompton NE; Keefe KA; Jentsch B; Perewusnyk G; Haller U; Köchli OR
Photochem Photobiol; 1998 Oct; 68(4):569-74. PubMed ID: 9796440
[TBL] [Abstract][Full Text] [Related]
71. Photodynamic therapy for lung cancer and malignant pleural mesothelioma.
Simone CB; Cengel KA
Semin Oncol; 2014 Dec; 41(6):820-30. PubMed ID: 25499640
[TBL] [Abstract][Full Text] [Related]
72. Biological responses of dog prostate and adjacent structures after meso-tetra-(m-hydroxyphenyl) chlorin and aluminum disulfonated phthalocyanine based photodynamic therapy.
Chang SC; Chern IF; Hsu YH
Proc Natl Sci Counc Repub China B; 1999 Oct; 23(4):158-66. PubMed ID: 10518316
[TBL] [Abstract][Full Text] [Related]
73. Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer.
Wyss P; Schwarz V; Dobler-Girdziunaite D; Hornung R; Walt H; Degen A; Fehr M
Int J Cancer; 2001 Sep; 93(5):720-4. PubMed ID: 11477585
[TBL] [Abstract][Full Text] [Related]
74. Effect of mTHPC-mediated photodynamic therapy on 5-fluorouracil resistant human colorectal cancer cells.
Kukcinaviciute E; Sasnauskiene A; Dabkeviciene D; Kirveliene V; Jonusiene V
Photochem Photobiol Sci; 2017 Jul; 16(7):1063-1070. PubMed ID: 28509917
[TBL] [Abstract][Full Text] [Related]
75. Intraperitoneal photodynamic therapy in the rat: comparison of toxicity profiles for photofrin and MTHPC.
Veenhuizen RB; Ruevekamp-Helmers MC; Helmerhorst TJ; Kenemans P; Mooi WJ; Marijnissen JP; Stewart FA
Int J Cancer; 1994 Dec; 59(6):830-6. PubMed ID: 7989125
[TBL] [Abstract][Full Text] [Related]
76. Photodynamic therapy using mTHPC for malignant disease in the oral cavity.
Fan KF; Hopper C; Speight PM; Buonaccorsi GA; Bown SG
Int J Cancer; 1997 Sep; 73(1):25-32. PubMed ID: 9334805
[TBL] [Abstract][Full Text] [Related]
77. Intrapleural photodynamic therapy: results of a phase I trial.
Pass HI; DeLaney TF; Tochner Z; Smith PE; Temeck BK; Pogrebniak HW; Kranda KC; Russo A; Friauf WS; Cole JW
Ann Surg Oncol; 1994 Jan; 1(1):28-37. PubMed ID: 7834425
[TBL] [Abstract][Full Text] [Related]
78. Magnetic Targeting of mTHPC To Improve the Selectivity and Efficiency of Photodynamic Therapy.
Haimov-Talmoud E; Harel Y; Schori H; Motiei M; Atkins A; Popovtzer R; Lellouche JP; Shefi O
ACS Appl Mater Interfaces; 2019 Dec; 11(49):45368-45380. PubMed ID: 31755692
[TBL] [Abstract][Full Text] [Related]
79. Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin.
Chang SC; Buonaccorsi G; MacRobert A; Bown SG
Int J Cancer; 1996 Aug; 67(4):555-62. PubMed ID: 8759616
[TBL] [Abstract][Full Text] [Related]
80. meso-Tetrahydroxyphenylchlorin-Conjugated Gold Nanoparticles as a Tool To Improve Photodynamic Therapy.
Haimov E; Weitman H; Polani S; Schori H; Zitoun D; Shefi O
ACS Appl Mater Interfaces; 2018 Jan; 10(3):2319-2327. PubMed ID: 29298037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
